Sweden· SE-20061011000018
Xeomin 100 enheter Pulver till injektionsvätska, lösning
A medicinal product containing clostridium botulinum neurotoxin type a (150kd), free of complexing proteins, registered in Sweden by Merz Pharmaceuticals GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins
- Manufacturer
- Merz Pharmaceuticals GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20061011000018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clostridium botulinum neurotoxin type a (150kd), free of complexing proteins in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBOTOXAllergan, Inc.
- FinlandAlluzienceIpsen Pharma
- SwitzerlandAlluzience, InjektionslösungIPSEN Pharma Schweiz GmbH
- CzechiaALLUZIENCEIPSEN PHARMA S.A.S., Paříž
- PolandAlluzienceIpsen Pharma
- BelgiumAlluzience 200 Speywood-Eenheden/mlIpsen Pharma
- SpainALLUZIENCE 200 UNIDADES SPEYWOOD/ML SOLUCION INYECTABLEIpsen Pharma
- FranceALLUZIENCE 200 unités Speywood/mL, solution injectableIPSEN PHARMA
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Alluzience, Bocouture
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe458b45-8cc4-46a9-9804-49b5190e3eba GET /v1/drugs/fe458b45-8cc4-46a9-9804-49b5190e3eba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20061011000018",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20061011000018",
"product_doc_link": "https://docetp.mpa.se/LMF/Xeomin%20powder%20for%20solution%20for%20injection%20SmPC_09001bee807a8159.pdf"
}See everything about clostridium botulinum neurotoxin type a (150kd), free of complexing proteins.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.